Aktuellt
SENASTE
Remedy reported a Q4 with revenue of EUR 13.6 million exactly in line with our estimates and an EBIT of EUR 2.1 (above our estimate of EUR 1.0 million). In its outlook for 2023 Remedy expect revenue to decline from the previous year with a negative EBIT. We have already estimated a revenue decline of around 10% and a negative EBIT of EUR 7 million in 2023. Remedy is investing in three of its five ongoing games, which of course is potentially good for the future profitability.
LÄS MER
